Developmental delay and behavioral disorders in 59 HIV-exposed uninfected infants.

BACKGROUND Antiretroviral therapy (ART) in HIV pregnant women has led to a dramatic decrease in the rate of HIV mother-to-child transmission but this benefit is counterbalanced with adverse effects related to in utero and neonatal exposure to ART. In 2013, some parents described neurodevelopmental disorders in their children. METHODS A standardized letter was sent to the 133 women who delivered in Nantes hospital from 01/01/2003 to 31/12/2012 (167 births). RESULTS Response rate was 33%. Over a 10-year period, 7 children had behavioral disorders and/or cognitive/developmental delay, 1 child had developmental delay + growth retardation and 2 experienced cancer. CONCLUSIONS We found a significant association between neurodevelopmental disorders, preterm birth and exposure to 3 nucleoside reverse transcriptase inhibitors (NRTIs). Further studies are needed and long-term follow-up into adulthood should continue.

[1]  Paige L. Williams,et al.  Meconium Atazanavir Concentrations and Early Language Outcomes in HIV-Exposed Uninfected Infants With Prenatal Atazanavir Exposure , 2015, Journal of acquired immune deficiency syndromes.

[2]  L. Mofenson,et al.  Safety of Pediatric HIV Elimination: The Growing Population of HIV- and Antiretroviral-Exposed but Uninfected Infants , 2014, PLoS medicine.

[3]  R. Tubiana,et al.  Association between Prenatal Exposure to Antiretroviral Therapy and Birth Defects: An Analysis of the French Perinatal Cohort Study (ANRS CO1/CO11) , 2014, PLoS medicine.

[4]  Paige L. Williams,et al.  Evaluation of Risk for Late Language Emergence After In Utero Antiretroviral Drug Exposure in HIV-exposed Uninfected Infants , 2013, The Pediatric infectious disease journal.

[5]  Paige L. Williams,et al.  Safety of Perinatal Exposure to Antiretroviral Medications: Developmental Outcomes in Infants , 2013, The Pediatric infectious disease journal.

[6]  M. Gissler,et al.  Preterm birth time trends in Europe: a study of 19 countries , 2013, BJOG : an international journal of obstetrics and gynaecology.

[7]  Paige L. Williams,et al.  Mental health functioning among children and adolescents with perinatal HIV infection and perinatal HIV exposure , 2011, AIDS care.

[8]  L. Mofenson,et al.  Antiretroviral Drugs for Preventing Mother-to-Child Transmission of HIV: A Review of Potential Effects on HIV-Exposed but Uninfected Children , 2011, Journal of acquired immune deficiency syndromes.

[9]  Paige L. Williams,et al.  Neurodevelopment and In Utero Antiretroviral Exposure of HIV-Exposed Uninfected Infants , 2010, Pediatrics.

[10]  R. Grunau,et al.  A Prospective Controlled Study of Neurodevelopment in HIV-Uninfected Children Exposed to Combination Antiretroviral Drugs in Pregnancy , 2006, Pediatrics.

[11]  R. Artuch,et al.  Hyperlactatemia in Human Immunodeficiency Virus–Uninfected Infants Who Are Exposed to Antiretrovirals , 2004, Pediatrics.

[12]  P. Rustin,et al.  Persistent mitochondrial dysfunction in HIV-1-exposed but uninfected infants: clinical screening in a large prospective cohort , 2003, AIDS.

[13]  L. Kalish,et al.  Lack of tumors in infants with perinatal HIV-1 exposure and fetal/neonatal exposure to zidovudine. , 1999, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.